Search
ROTATEQ, Solution orale [V]
Details
| --- | Description |
|---|---|
| Pack | Boîte de 1 tube unidose de 2 ml |
| Strength (Dosage) | 3,01 * 106 UI / dose | 4,39 * 106 UI / dose | 5,98 * 106 UI / dose | 3,51 * 106 UI / dose | 4,13 * 106 UI / dose |
| Laboratory | MSD MAROC |
| Ingredients | G1 reassortant G2 reassortant G3 reassortant G4 reassortant P1 reassortant |
| Therapeutic class | Vaccins vivants atténués (Gastro-entérite) |
| ATC code | J07BH02 |
| PPH | $14.60 |
| PPV | $23.30 |
| Refundable | No |
| Refund base | $0.00 |
| Refund rate | $0.00 |
| Table | none |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | RotaTeq est indiqué pour l’immunisation active des nourrissons de l’âge de 6 semaines à 32 semaines pour la prévention des gastro-entérites dues à une infection à rotavirus. RotaTeq doit être utilisé sur la base des recommandations officielles. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem